Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
The American Journal of Pathology|July 24, 2017
Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma DisseminationJean-Pierre Gagner, Yasmeen Sarfraz, Valerio Ortenzi, et al.
Journal of Neurology|May 11, 2024
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplamClaudia A Chiriboga, Claudio Bruno, Tina Duong, et al.
Lancet (London, England)|December 13, 2016
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
The Lancet. Child & Adolescent Health|June 5, 2021
Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation studyRichard S Finkel, Claudia A Chiriboga, Jiri Vajsar, et al.
Neurology and Therapy|February 13, 2023
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH StudyClaudia A Chiriboga, Claudio Bruno, Tina Duong, et al.
Journal of Neurosurgery. Pediatrics|October 15, 2013
Reduction in upper-extremity tone after lumbar selective dorsal rhizotomy in children with spastic cerebral palsyPaul Gigante, Michael M McDowell, Samuel S Bruce, et al.
Journal of Pediatric Rehabilitation Medicine|July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophyMaria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 19, 2020
Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophyDenise M Kay, Colleen F Stevens, April Parker, et al.
Neurology|April 26, 2019
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studiesBasil T Darras, Claudia A Chiriboga, Susan T Iannaccone, et al.
Neurology|July 14, 2022
Newborn Screening for Spinal Muscular Atrophy in New York State: Clinical Outcomes From the First 3 YearsBo Hoon Lee, Stella Deng, Claudia A Chiriboga, et al.
Pageof 21